Background: Dengue fever is a very common viral infection with potential serious complications and is one of the WHO challenges to limit its spread especially in view of lacking specific treatment or approved vaccine. We noticed over long time frequent cases of dengue fever with some characteristic laboratory findings particularly leukopenia, thrombocytopenia and elevated liver enzymes. These findings sometimes give concerns about safety of the patients so admission and sometimes isolation that could be unnecessary for some patients. Objectives: To present our data about variable clinical presentations and laboratory changes associated with dengue fever infection in adults and complications encountered in our institute in Saudi Arabia. So that we can give recommendations about the diagnosis, management and protection. Methods: We included all dengue fever positive cases starting September 2007 till end of December 2014. The data gathered through tracking the records of patients requested for Dengue fever serology in the main laboratory of the International Medical Centre (IMC). Data for analysis: Age, gender, characteristic laboratory changes, clinical manifestations and complications. Results: Dengue fever is a self-limiting viral infection in the majority of cases. Incidence of dengue infection in males: females is 2:1. Dengue fever manifestations in order of frequency: Fever, body aches, gastro intestinal symptoms, headache, and skin rash and chest symptoms. Incidence of complications in our study was 5.5%.
| Published in | American Journal of Internal Medicine (Volume 4, Issue 6) |
| DOI | 10.11648/j.ajim.20160406.11 |
| Page(s) | 93-100 |
| Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
| Copyright |
Copyright © The Author(s), 2016. Published by Science Publishing Group |
Dengue, Fever, Virus, Infection, Manifestations of Dengue Fever
| [1] | www.cdc.gov/dengue/resources/30Jan2012/aegyptifactsheet.pdf |
| [2] | Teoh, E. P., Kukkaro, P., Teo, E. W., Lim, A. P., Tan, T. T., Yip, A., … MacAry, P. A. (2012). The structural basis for serotype-specific neutralization of dengue virus by a human antibody. Sci Transl Med, 4 (139), 139ra83. http://doi.org/10.1126/scitranslmed.3003888 |
| [3] | Sangkawibha, N., Rojanasuphot, S., Ahandrik, S., Viriyapongse, S., Jatanasen, S., Salitul, V., … Halstead, S. B. (1984). Risk factors in dengue shock syndrome: a prospective epidemiologic study in Rayong, Thailand. I. The 1980 outbreak. American Journal of Epidemiology, 120 (5), 653–669. http://doi.org/10.1093/aje/155.5.478 |
| [4] | Midgley, C. M., Bajwa-Joseph, M., Vasanawathana, S., Limpitikul, W., Wills, B., Flanagan, A., … Screaton, G. R. (2011). An in-depth analysis of original antigenic sin in dengue virus infection. Journal of Virology, 85 (1), 410–421. http://doi.org/10.1128/JVI.01826-10 |
| [5] | OhAinle, M., Balmaseda, A., Macalalad, A. R., Tellez, Y., Zody, M. C., Saborio, S., … Harris, E. (2011). Dynamics of Dengue Disease Severity Determined by the Interplay between Viral Genetics and Serotype-Specific Immunity. Science Translational Medicine, 3 (114), 114ra128–114ra128. http://doi.org/10.1126/scitranslmed.3003084 |
| [6] | SB Halstead, Dengue: Overview and History. DENGUE Chapter 1 Imperial College press. |
| [7] | Halstead, S. B. (2007). Dengue. Lancet. http://doi.org/10.1016/S0140-6736(07)61687-0www.cdc.gov/dengue/resources/30Jan2012/aegyptifactsheet.pdf |
| [8] | Bhatt, S., Gething, P. W., Brady, O. J., Messina, J. P., Farlow, A. W., Moyes, C. L., … Hay, S. I. (2013). The global distribution and burden of dengue. Nature, 496 (7446), 504–507. http://doi.org/10.1038/nature12060 |
| [9] | WHO2016DengueandsevereDengue http://www.who.int/mediacentre/factsheets/fs117/en/ |
| [10] | Kularatne Senanayake A M. Dengue fever BMJ 2015; 351: h4661 Doi: http://dx.doi.org/10.1136/bmj.h4661 |
| [11] | Webster, D. P., Farrar, J., & Rowland-Jones, S. (2009). Progress towards a dengue vaccine. The Lancet Infectious Diseases. http://doi.org/10.1016/S1473-3099(09)70254-3 |
| [12] | Tom Clarke Dengue virus: Break-bone fever Nature. Doi: 10.1038/news020415-10. |
| [13] | Kurane, I. (2007). Dengue hemorrhagic fever with special emphasis on immunopathogenesis. Comparative Immunology, Microbiology and Infectious Diseases, 30 (5-6), 329–340. http://doi.org/10.1016/j.cimid.2007.05.010 |
| [14] | Ana P. Goncalvez, Ronald E. Engle, Marisa St. Claire, Robert H. Purcell, and Ching-Juh Lai monoclonal antibody-mediated enhancement of dengue virus infection in vitro and in vivo and strategies for prevention, PNAS vol. 104 no. 22, Doi: 10.1073/pnas.0703498104. |
| [15] | Hasan, S., Jamdar, S. F., Alalowi, M., & Al Ageel Al Beaiji, S. M. (2016). Dengue virus: A global human threat: Review of literature. Journal of International Society of Preventive & Community Dentistry, 6 (1), 1–6. http://doi.org/10.4103/2231-0762.175416 |
| [16] | Yacoub, S., Mongkolsapaya, J., & Screaton, G. (2016). Recent advances in understanding dengue. F1000Research, 5, F1000 Faculty Rev–78. http://doi.org/10.12688/f1000research.6233.1 |
| [17] | Annelies Wilder-Smith, M. D., Ph.D., and Eli Schwartz, M. D. Dengue in Travelers. N Engl J Med 2005; 353: 924-932 DOI: 10.1056/NEJMra041927. |
| [18] | Gubler, D. J. (1998). Dengue and Dengue Hemorrhagic Fever. Clinical Microbiology Reviews, 11 (3), 480–496. |
| [19] | Ishak IH, Riveron JM, Ibrahim SS, Stott R, Longbottom J, Irving H, Wondji CS. (2016). The Cytochrome P450 gene CYP6P12 confers pyrethroid resistance in kdr-free Malaysian populations of the dengue vector Aedes albopictus. 2016 Apr 20; 6: 24707. doi: 10.1038/srep24707. |
| [20] | Basile Kamgang, Sébastien Marcombe, Fabrice Chandre, Elysée Nchoutpouen, Philippe Nwane, Josiane Etang, Vincent Corbe and Christophe Paupy. (2011), Insecticide susceptibility of Aedes aegypti and Aedes albopictus in Central Africa. Parasites & Vectors 4: 79. DOI: 10.1186/1756-3305-4-79. |
| [21] | Gubler, D. J. (2002). Epidemic dengue/dengue hemorrhagic fever as a public health, social and economic problem in the 21st century. Trends in Microbiology. http://doi.org/10.1016/S0966-842X(01)02288-0 |
| [22] | Kow, C. Y., Koon, L. L., & Yin, P. F. (2001). Detection of Dengue Viruses in Field Caught Male Aedes aegypti and Aedes albopictus (Diptera: Culicidae) in Singapore by Type-Specific PCR. Journal of Medical Entomology, 38 (4), 475–479. http://doi.org/10.1603/0022-2585-38.4.475 |
| [23] | M. A. LORON˜ O-PINO, C. B. CROPP, J. A. FARFA´ N, A. V. VORNDAM, E. M. RODRI´GUEZ-ANGULO, E. P. ROSADO-PAREDES, L. F. FLORES-FLORES, B. J. BEATY, AND D. J. GUBLER (1999). Common occurrence of concurrent infections by multiple dengue virus serotypes. American Journal of Tropical Medicine and Hygiene, 61 (5), 725–730. |
| [24] | Gubler, D. J., & Trent, D. W. (1993). Emergence of epidemic dengue/dengue hemorrhagic fever as a public health problem in the Americas. Infect Agents Dis, 2 (6), 383–393. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/8012739 |
| [25] | Burke, D. S., Nisalak, A., Johnson, D. E., & Scott McN., R. (1988). A prospective study of dengue infections in Bangkok. American Journal of Tropical Medicine and Hygiene, 38 (1), 172–180. |
| [26] | Scott, T. W., Naksathit, A., Day, J. F., Kittayapong, P., & Edman, J. D. (1997). A fitness advantage for Aedes aegypti and the viruses it transmits when females feed only on human blood. American Journal of Tropical Medicine and Hygiene, 57 (2), 235–239. |
| [27] | Platt, K. B., Linthicum, K. J., Myint, K. S., Innis, B. L., Lerdthusnee, K., & Vaughn, D. W. (1997). Impact of dengue virus infection on feeding behavior of Aedes aegypti. The American Journal of Tropical Medicine and Hygiene, 57 (2), 119–125. |
| [28] | Gubler, D. J., Suharyono, W., Tan, R., Abidin, M., & Sie, A. (1981). Viraemia in patients with naturally acquired dengue infection. Bulletin of the World Health Organization, 59 (4), 623–630. |
| [29] | Vaughn, D. W., Green, S., Kalayanarooj, S., Innis, B. L., Nimmannitya, S., Suntayakorn, S., … Nisalak, a. (1997). Dengue in the early febrile phase: viremia and antibody responses. The Journal of Infectious Diseases, 176, 322–330. http://doi.org/10.1086/514048 |
| [30] | Vairo F, Mboera LE, De Nardo P, Oriyo NM, Meschi S, Rumisha SF, Colavita F, Mhina A, Carletti F, Mwakapeje E, Capobianchi MR, Castilletti C, Di Caro A, Nicastri E, Malecela MN, Ippolito G. Clinical, Virologic, and Epidemiologic Characteristics of Dengue Outbreak, Dar es Salaam, Tanzania, 2014. Emerg Infect Dis. 2016 May; 22 (5): 895-9. doi: 10.3201/eid2205.151462. |
| [31] | Pang, E. L., & Loh, H.-S. (2016). Current perspectives on dengue episode in Malaysia. Asian Pacific Journal of Tropical Medicine, 9 (4), 395–401. http://doi.org/10.1016/j.apjtm.2016.03.004 |
| [32] | Rigauperez, J., Clark, G., Gubler, D., Reiter, P., Sanders, E., & Vancevorndam, a. (1998). Dengue and dengue haemorrhagic fever. The Lancet, 352 (9132), 971–977. http://doi.org/10.1016/S0140-6736(97)12483-7 |
| [33] | Hales, S., N, de W., Maindonald, J., & Woodward, A. (2002). Potential effect of population and climate changes on global distribution of dengue fever: an empirical model. The Lancet, 360, 830–834. http://doi.org/10.1016/S0140-6736(02)09964-6 |
| [34] | Martina, B. E. E., Koraka, P., & Osterhaus, A. D. M. E. (2009). Dengue virus pathogenesis: An integrated view. Clinical Microbiology Reviews. http://doi.org/10.1128/CMR.00035-09 |
| [35] | Hadinegoro, S. R. S. (2012). The revised WHO dengue case classification: does the system need to be modified? Paediatrics and International Child Health, 32 Suppl 1, 33–8. http://doi.org/10.1179/2046904712Z.00000000052 |
| [36] | Dengue - Guidelines for diagnosis, treatment, prevention and control Publication date: 1 October 2009. WHO reference number: WHO/HTM/NTD/DEN/2009.1 |
| [37] | Szreter, S. (2004). Industrialization and health. British Medical Bulletin. http://doi.org/10.1093/bmb/ldh005 |
APA Style
Mohammed Salah Debes, Mohamed Al Tayeb, Momen Faysal Nassani, Ahmed Abdullah Basaeed, Anas Dwaima, et al. (2016). Dengue Fever in Adults, a Retrospective Study. American Journal of Internal Medicine, 4(6), 93-100. https://doi.org/10.11648/j.ajim.20160406.11
ACS Style
Mohammed Salah Debes; Mohamed Al Tayeb; Momen Faysal Nassani; Ahmed Abdullah Basaeed; Anas Dwaima, et al. Dengue Fever in Adults, a Retrospective Study. Am. J. Intern. Med. 2016, 4(6), 93-100. doi: 10.11648/j.ajim.20160406.11
AMA Style
Mohammed Salah Debes, Mohamed Al Tayeb, Momen Faysal Nassani, Ahmed Abdullah Basaeed, Anas Dwaima, et al. Dengue Fever in Adults, a Retrospective Study. Am J Intern Med. 2016;4(6):93-100. doi: 10.11648/j.ajim.20160406.11
Share This Article
Twitter
Linked In
Facebook
Copy
Download@article{10.11648/j.ajim.20160406.11,
author = {Mohammed Salah Debes and Mohamed Al Tayeb and Momen Faysal Nassani and Ahmed Abdullah Basaeed and Anas Dwaima and Moahmmed Khaldoun Alsaadi and Hassan Odah},
title = {Dengue Fever in Adults, a Retrospective Study},
journal = {American Journal of Internal Medicine},
volume = {4},
number = {6},
pages = {93-100},
doi = {10.11648/j.ajim.20160406.11},
url = {https://doi.org/10.11648/j.ajim.20160406.11},
eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ajim.20160406.11},
abstract = {Background: Dengue fever is a very common viral infection with potential serious complications and is one of the WHO challenges to limit its spread especially in view of lacking specific treatment or approved vaccine. We noticed over long time frequent cases of dengue fever with some characteristic laboratory findings particularly leukopenia, thrombocytopenia and elevated liver enzymes. These findings sometimes give concerns about safety of the patients so admission and sometimes isolation that could be unnecessary for some patients. Objectives: To present our data about variable clinical presentations and laboratory changes associated with dengue fever infection in adults and complications encountered in our institute in Saudi Arabia. So that we can give recommendations about the diagnosis, management and protection. Methods: We included all dengue fever positive cases starting September 2007 till end of December 2014. The data gathered through tracking the records of patients requested for Dengue fever serology in the main laboratory of the International Medical Centre (IMC). Data for analysis: Age, gender, characteristic laboratory changes, clinical manifestations and complications. Results: Dengue fever is a self-limiting viral infection in the majority of cases. Incidence of dengue infection in males: females is 2:1. Dengue fever manifestations in order of frequency: Fever, body aches, gastro intestinal symptoms, headache, and skin rash and chest symptoms. Incidence of complications in our study was 5.5%.},
year = {2016}
}
TY - JOUR T1 - Dengue Fever in Adults, a Retrospective Study AU - Mohammed Salah Debes AU - Mohamed Al Tayeb AU - Momen Faysal Nassani AU - Ahmed Abdullah Basaeed AU - Anas Dwaima AU - Moahmmed Khaldoun Alsaadi AU - Hassan Odah Y1 - 2016/11/10 PY - 2016 N1 - https://doi.org/10.11648/j.ajim.20160406.11 DO - 10.11648/j.ajim.20160406.11 T2 - American Journal of Internal Medicine JF - American Journal of Internal Medicine JO - American Journal of Internal Medicine SP - 93 EP - 100 PB - Science Publishing Group SN - 2330-4324 UR - https://doi.org/10.11648/j.ajim.20160406.11 AB - Background: Dengue fever is a very common viral infection with potential serious complications and is one of the WHO challenges to limit its spread especially in view of lacking specific treatment or approved vaccine. We noticed over long time frequent cases of dengue fever with some characteristic laboratory findings particularly leukopenia, thrombocytopenia and elevated liver enzymes. These findings sometimes give concerns about safety of the patients so admission and sometimes isolation that could be unnecessary for some patients. Objectives: To present our data about variable clinical presentations and laboratory changes associated with dengue fever infection in adults and complications encountered in our institute in Saudi Arabia. So that we can give recommendations about the diagnosis, management and protection. Methods: We included all dengue fever positive cases starting September 2007 till end of December 2014. The data gathered through tracking the records of patients requested for Dengue fever serology in the main laboratory of the International Medical Centre (IMC). Data for analysis: Age, gender, characteristic laboratory changes, clinical manifestations and complications. Results: Dengue fever is a self-limiting viral infection in the majority of cases. Incidence of dengue infection in males: females is 2:1. Dengue fever manifestations in order of frequency: Fever, body aches, gastro intestinal symptoms, headache, and skin rash and chest symptoms. Incidence of complications in our study was 5.5%. VL - 4 IS - 6 ER -
Email: